advertisement-vertical Download Proto magazine app
Social Icons
WHEN A PROTEIN MISFOLDS:

It’s unable to perform crucial work within the cell // or it bands together with other such proteins to cause havoc // and sets in motion a wide variety of disorders.

Protein Misfolding: Origami Medicine

By Lauren Ware // Photographs by Denise Bosco // Spring 2010
icon-pdfpdf icon-printprint
share: digg.com del.icio.us facebook.com
origami medicine

Denise Bosco for Proto

The proteostasis network has always existed, but the name is new, and only recently emerging is the notion that the network is as essential to life as a beating heart or DNA. Proteostasis is what the cell aspires to: a state of equilibrium in which the many proteins inside it coexist and interact. When the network is perfectly balanced, it’s a hallmark of a healthy cell—and of any healthy organism, from the primitive worm Caenorhabditis elegans to the gloriously complex human. But when it’s unbalanced—because of defective proteins, aging, physiological stress or other factors—disease results.

Despite its name, proteostasis is anything but static. There’s constant activity, as every day the cells of the human body pump out thousands of proteins that carry out a remarkable range of functions, from preventing lung tissue damage to transporting crucial ions across membranes and stabilizing nerve cells. To achieve these functions, proteins must fold into specific three-dimensional shapes, find their way to their destinations and, if defective or no longer needed, degrade to make way for newly synthesized replacements. A network of more than 1,000 enzymes, molecular chaperones and other components controls these processes. Numerous signaling molecules work together in pathways that respond to cues from the cell or its environment to regulate the number of chaperones, enzymes and components.

William Balch, professor of cell biology at the Scripps Research Institute in La Jolla, Calif., whose work focuses on the pathways of proteostasis, describes the process of folding, transporting and chaperoning a protein: “It’s like raising a kid. After he’s born, you don’t just put him out on the street. You work with him. The cell is working all the time with the proteins that it makes on a minute-by-minute basis.” Each cell must ensure that proteins are made to proper specifications, maintained in the three-dimensional shape that allows them to work properly, and launched into adulthood in a way that supports the cell’s overall health.

Though many scientists are now focused on deciphering the details of the system, progress has been frustratingly slow, and the more researchers learn, the more complexities they unearth. Discovering the processes and interactions involved in just one pathway may take years. But there’s an urgency underlying this work, because folding errors and other protein defects are known or suspected to be implicated in many devastating diseases, from cystic fibrosis to Huntington’s, Alzheimer’s and type 2 diabetes.

One tack medical science has taken is to try to treat these disorders with gene therapy—replace the defective gene that produces the aberrant protein. Researchers have also looked for ways to introduce a “normal,” or “wild type,” version of the protein into a cell. For example, with a degenerative nerve disease known as transthyretin (TTR) amyloid polyneuropathy, caused by a misfolded protein produced by the liver, a transplanted liver cures the condition by making perfect, wild-type TTR that doesn’t cause problems. But in most cases, these methods haven’t proved effective, so the treatment of misfolding disorders has usually been relegated to relieving symptoms.

Recently, however, researchers have begun exploring ways that science can influence parts of the process, tweaking the diseased system with drugs designed to bring proteostasis back into balance. In some cases, they’ve been able to make partial molecular fixes that help a misfolded protein achieve its original purpose. Sometimes, it turns out, perfection isn’t needed, and “good enough” solutions, hurried from concept to drug discovery through a process of high-technology trial and error, may get the job done—often years in advance of more complete or elegant therapies.

previous // next
icon-pdfpdf icon-printprint
share: digg.com del.icio.us facebook.com
Stat-arrow-green

Folding Fixers

Misshapen proteins are implicated in a wide array of disorders. Here are just a few, and how drugs might restore function to errant proteins.

Stat-arrow-gold
hed-dossier

1. “Biological and Chemical Approaches to Diseases of Proteostasis Deficiency,” by Evan T. Powers et al., Annual Review of Biochemistry, 2009. An in-depth, highly technical look at the way defective protein maintenance is implicated in diseases, as well as how small molecules can enhance proteostasis.

2. “Adapting Proteostasis for Disease Intervention,” by William E. Balch et al., Science, Feb. 15, 2008. A succinct explanation of how proteostasis offers insights into research for treatment of loss-of-function and gain-of-function misfolding disorders.

3. “Researching the Surface in CF,” by Lev Osherovich, SciBX: Science-Business eXchange, Jan. 7, 2010. An overview of potential avenues for correcting the CFTR protein, including Vertex’s compounds and William Balch’s work with HDAC inhibitors.

Protomag on Facebook Protomag on Twitter